Matthew R. Hawes
About Matthew R. Hawes
Matthew R. Hawes serves as the Area Sales Director for the West at BridgeBio, bringing extensive experience from roles at Gilead Sciences, Global Blood Therapeutics, and Pfizer. He is dedicated to improving access to innovative treatments for underserved populations and has a strong network in the biotech and pharmaceutical sectors.
Current Role at BridgeBio
Matthew R. Hawes serves as the Area Sales Director - West at BridgeBio since 2024. In this role, he is responsible for overseeing sales strategies and operations in the Western United States. His position is remote, allowing him to manage a diverse team and engage with various stakeholders across the region.
Previous Experience at Gilead Sciences
Matthew R. Hawes held multiple positions at Gilead Sciences. He worked as Regional Director from 2013 to 2015 in the Greater Chicago Area. Later, he served as Associate Director of Marketing from 2015 to 2017 and as Director of Commercial Operations from 2017 to 2018, both in the San Francisco Bay Area. His tenure at Gilead involved leadership roles that contributed to the company's strategic initiatives.
Background in Pharmaceutical Sales
Matthew R. Hawes has extensive experience in pharmaceutical sales and operations. He worked as Regional Sales Manager at Optimer Pharmaceuticals from 2011 to 2013, covering Illinois and Missouri. He then transitioned to Global Blood Therapeutics, where he served as Regional Business Director from 2019 to 2020 and Senior Zone Director - West from 2020 to 2022, both in the San Francisco Bay Area.
Education and Expertise
Matthew R. Hawes earned a Bachelor of Arts degree in Communication, Journalism, and Related Programs from Loyola University Chicago. His educational background supports his expertise in sales and marketing within the biotech and pharmaceutical sectors, enhancing his communication skills and strategic thinking.
Commitment to Health Equity
Matthew R. Hawes is passionate about ensuring access to innovative treatments for underserved populations. He emphasizes health equity in his professional endeavors, reflecting a commitment to addressing disparities in healthcare access and outcomes.